Bavarian Nordic Secures Four-Year Contract from UK for Monkeypox and Smallpox Vaccine

Bavarian Nordic has signed a four-year contract with the UK government for the supply of vaccines against monkeypox (mpox) and smallpox. According to Reuters, the agreement covers the supply of the company's relevant vaccine products to the United Kingdom. The four-year term of the contract is notable as it strengthens Bavarian Nordic's long-term supply relationships in the public health sector. Financial details of the agreement and information on supply volume are not included in the source. Monkeypox and smallpox are among the diseases closely monitored by public health authorities. The UK government's decision to enter into a long-term supply agreement in this area is seen as a step toward the sustainability of vaccine stocks. Bavarian Nordic is among the companies active in the production of these vaccines. The report does not share additional information on the terms of the agreement or the company's financial expectations. Not investment advice.